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Background: In 2004, artemisinin-based combination therapy (ACT) was introduced in Sudan for the treatment
of malaria. The role of health care providers working in first-level health care facilities is central for the effective
implementation of this revised malaria treatment policy. However, information about their level of ACT knowledge
is inadequate. This study sought to describe frontline health care providers’ knowledge about the formulations and
dose regimens of nationally recommended ACT in Sudan.
Methods: This cross-sectional study took place in Gezira State, Sudan. Data were gathered from five localities
comprising forty primary health care facilities. A total of 119 health care providers participated in the study (72
prescribers and 47 dispensers). The primary outcome was the proportion of health care providers who were ACT
knowledgeable, a composite indicator of health care providers’ ability to (1) define what combination therapy is;
(2) identify the recommended first- and second-line treatments; and (3) correctly state the dose regimens for each.
Results: All prescribers and 95.7% (46/47) of dispensers were aware of the new national malaria treatment policy.
However, 93.1% (67/72) of prescribers compared to 87.2% (41/47) of dispensers recognized artesunate-sulphadoxine/
pyrimethamine as the recommended first-line treatment in Sudan. Only a small number of prescribers and dispensers
(9.4% and 13.6%, respectively) were able to correctly define the meaning of a combination therapy. Overall, only
22% (26/119, 95% CI 14.6-29.4) of health care providers were found to be ACT knowledgeable with no statistically
significant difference between prescribers and dispensers.
Conclusion: Overall, ACT knowledge among frontline health care providers is very poor. This finding suggests that
efforts are needed to improve knowledge of prescribers and dispensers working in first-level health care facilities,
perhaps through implementing focused, provider-oriented training programmes. Additionally, a system for
regularly monitoring and evaluating the quality of in-service training may be beneficial to ensure its responsiveness
to the needs of the target health care providers.Background
Malaria continues to be a major public health problem
in most African countries including Sudan [1,2]. In 2001,
the WHO recommended the use of artemisinin–based
combination therapy (ACT) for treating malaria due to its
rapid clearance of parasitaemia and high cure rate [3-5].
While costly compared with other anti-malarials, ACT is* Correspondence: abeeratta@gmail.com
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its malaria treatment policy and switched to ACT [9].
Currently, the nationally recommended first line and
second line treatments are artesunate-sulphadoxine/pyri-
methamine (ASP) and artemether-lumefantrine (AL),
respectively. ASP is widely accessible and offered free of
charge in primary health care facilities in Sudan. However,
the successful implementation of the ACT treatment pol-
icy largely depends upon adequate training and support
for health care providers to improve their knowledge and
to ensure their acceptance and adherence to the newl. This is an Open Access article distributed under the terms of the Creative
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treatment guidelines has been cited in the literature as an
important prerequisite for effective malaria case manage-
ment [11]. Nationally, no sufficient information is avail-
able that describes how much prescribers and dispensers
of ACT know about this effective treatment, which is cur-
rently the best hope for treating malaria worldwide. This
study was undertaken to assess the level of knowledge of
health care providers working in public primary health
care units about ACT in terms of its definition, recom-
mended formulations, and dosages. Primary health care
providers were specifically targeted given their role in the
workforce on the frontlines where they manage the great-
est proportion of malaria patients. Primary health care
providers have a responsibility to the welfare of their pa-
tients through regularly updating their knowledge to en-
sure proper malaria case management. Although correct
knowledge of health care providers does not necessarily
mean adherence to treatment guidelines [12,13], deter-
mining their level of knowledge is essential for under-
standing the malaria treatment situation in Sudan. It was
anticipated that the results of this survey would contribute
to the evidence describing the use of ACT in Sudan, and
would inform the need for possible investment in targeted
training programmes to ensure the delivery of better qual-
ity malaria treatment services.
Methods
Study setting
This survey was carried out in Gezira state, Sudan. Data
were collected from 40 primary health care facilities lo-
cated in five localities; namely Greater Medani, Gezira
south, Gezira east, Hasheesa, and Kamleen .
Study population
A multi-stage sampling technique was employed to
select the study participants. In the first stage, five local-
ities were randomly selected. In the second stage, a sam-
ple of 40 primary health care facilities was randomly
drawn. In the final stage, all health care providers (pre-
scribers and dispensers) working in the selected health
facilities at the time of the study were interviewed.
Data collection
A structured interview was conducted to assess three di-
mensions of health care providers’ knowledge using pre-
coded and pre-tested questionnaire. First, their general
knowledge regarding ACT definition and its introduction
as the first-line treatment in Sudan was assessed. Second,
knowledge about the routes and dosages of the nationally
recommended first-, second- and third-line treatments was
assessed. Third, it was investigated whether they perceived
the ACT treatment guidelines as effective, and the ACT
wall charts as clear and informative. For the prescribers, anadditional dimension was explored, which was their back-
ground knowledge about malaria case definition, mode of
diagnosis, and their prescribing habits.
Data analysis
The main outcome of this study was the proportion of
health care providers who demonstrated an adequate
knowledge about ACT guidelines for treating uncompli-
cated malaria. This was defined by health care providers’
ability to (1) define what combination therapy is; (2) iden-
tify the recommended first- and second-line treatments;
and (3) correctly state the dose regimens for each. Data
were entered and analysed using SPSS version 22.
Ethical approval
Ethical approval for this study was provided by the Al
Neelain University institutional review board, the National
Fund for Promoting Medical Services, and the Gezira
State Ministry of Health. The purpose of the study was
fully explained to all participants, and their verbal consent
was obtained prior to conducting the interviews.
Results
A total of 72 prescribers and 47 dispensers participated
in the study. All prescribers and 95.7% (46/47) of dis-
pensers were aware of the national malaria treatment
guidelines (Table 1). ASP was identified as the recom-
mended first-line treatment in Sudan by 93.1% (67/72)
of prescribers and 87.2% (41/47) of dispensers. With the
exception of only one prescriber, all health care providers
indicated the oral route as the recommended mode of
ASP administration. Over 30% (83/119) of health care
providers were unable to distinguish the difference be-
tween ASP as a combination therapy and the formerly
recommended first-line anti-malarial (i.e. chloroquine). A
very few number of prescribers and dispensers (9.4%
and 13.6%, respectively) were able to correctly define
the meaning of a combination therapy.
Although the majority of heath care providers recog-
nized ASP as the first-line treatment, their knowledge
about the recommended dosage in milligrams and the
number of tablets in a full course was very low in both
groups (Table 2).
Regarding recommended second-line treatment, only
66.7% (48/72) of prescribers and51.1% (24/47) of dis-
pensers were able to recognize artemether/lumefantrine
(AL) as the treatment of choice. Similarly, the level of
knowledge about the correct dosage and amount was very
low among both prescribers and dispensers (Table 2).
Overall, only 22% (26/119, 95% CI 14.6-29.4) of health
care providers were considered ACT-knowledgeable with
no statistically significant difference between the two
groups. More prescribers participated in this study com-
pared to dispensers. That was a true reflection of the
Table 1 Knowledge of health care providers (HPs) about ACT treatment policy
Domain Prescribers Dispensers Total 95% CI Chi-square P. value
N = 72 N = 47 N = 119
n (%) n (%) n (%)
HP heard of new national treatment guidelines for malaria 72 46 118 97.6-100 1.545 0.395
100 95.7 99.2
HP recognized Artesunate- sulphadoxine/pyrimethamine
(ASP) as the recommended first-line treatment for malaria
67 41 108 85.6-96 3.495 0.321
93.1 87.2 90.8
HP identified ASP as a combination therapy 51 32 83 61.4-78 1.667 0.644
70.8 68.1 69.7
HP defined a Combination therapy correctly 7 6 13 5.3-16.5 2.727 0.604
9.4 13.6 10.9
HP recognized the oral route for ASP as the nationally
recommended
71 47 118 97.6-100 0.658 1
98.6 100 99.2
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primary health care facilities in Sudan.
Knowledge about third-line treatment was compar-
ably higher in both groups. Quinine tablets were identi-





HP recognized Artesunate-sulphadoxine/pyrimethamine (ASP)
as the first-line treatment
67
93.1
HP stated the recommended dose for ASP in mg correctly 22
32.8
HP recognized how ASP is taken correctly 44
61.1




HP stated the recommended dose for AL in mg correctly 26
36.1
HP recognized how AL is taken correctly. 46
63.9
HP recognized quinine as the third-line treatment 60
83.3
HP stated the recommended dose for oral quinine correctly 56
77.8
HP recognized the main indication for administering injectable





*ACT knowledgeable = HP identified ACT as a combination therapy + HP recognized
recognized how ASP is taken correctly + HP recognized Artemether/lumefantrine (ASudan by83.3% (60/72) of prescribers and 89.4% (42/47)
of dispensers. Regarding the recommended quinine
dosage, the level of knowledge was significantly higher
among prescribers (P value = 0.00). A considerably low
number of health care providers (64.8% of prescribersoutes and doses of the; first, second and third line
rs Dispensers Total 95% CI Chi-square P. value
N = 47 N = 119
n (%) n (%)
43 110 87.6-97.2 0.332 0.847
91.5 92.4
13 35 21.9-38 1.787 0.618
29.5 29.7
24 68 49.0-66.8 1.172 0.279
51.1 57.1
24 72 51.7-69.3 7.084 0.069
51.1 60.5
16 42 26.7-43.9 1.800 0.407
34 35.3
24 70 50.0-67.6 1.932 0.381
51.1 58.8
42 102 79.4-92.2 4.201 0.122
89.4 85.7
18 74 53.5-71.0 20.732 0.000
38.3 62.2
32 75 54.3-71.1 1.358 0.715
68.1 63
10 26 14.6-29.4 0.026 1
21.3 22
Artesunate-sulphadoxine/pyrimethamine (ASP) as the first-line treatment + HP
L) as the second-line treatment + HP recognized how AL is taken correctly.
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the indication for administering quinine injections for
malaria confirmed patients.
The vast majority of prescribers (90.3%, 65/72) and dis-
pensers (95.7%, 45/47) perceived ASP as effective. Never-
theless, only a few of them have been trained on the use
of the ACT guidelines (Table 3). More dispensers (93.3%,
42/47) perceived the malaria treatment wall charts as
informative and clear compared to prescribers (86.1%, 62/
72), though the difference was not statistically different.
This investigation also included additional questions
specifically developed to obtain further information about
prescribers’ background knowledge of malaria case defin-
ition, their attitudes towards malaria laboratory diagnosis,
and whether they prescribe ASP as the first-line in their
practice (Table 4). 44.4% (32/72) of prescribers adequately
defined a case of malaria. Alarmingly, only 22.4% (15/72)
of prescribers indicated that they rely on the laboratory re-
sults to confirm malaria diagnosis. Also, it was found that
although 90.3% (65/72) of prescribers described ASP as ef-
fective, only 63.2% (47/72) of them have stated that they
actually prescribe it as the first treatment option for un-
complicated malaria in their routine practice.
Discussion
Health care providers working in primary health care
facilities in Sudan play an essential role in delivering care
for patients with malaria. However, in low income-
countries health care providers have been found to per-
form below their potential due to factors such as heavy
workload coupled with shortage of staff [14,15]. Fur-
thermore, evidence has shown that primary health care
providers in resource-restricted countries sometimes
lack support and can be dissatisfied [16,17]. One of the
main challenges facing primary health care providers in
Sudan is the rising number of malaria patients present-
ing to health care facilities, in particular during the
rainy season [18]. Malaria treatment guidelines have
changed following the introduction of ACT in 2004.




HP describes ASP as effective 65
90.3
HP describes the treatment guidelines wall chart as clear 62
86.1
HP received training on national treatment guidelines 18
25.0accompanied by several measures to ensure its effective
implementation, including in-service training of health
care providers to regularly update their knowledge and
improve their skills.
The results of this study have shown a significant know-
ledge gap among primary health care providers about the
ACT policy. Although the vast majority of prescribers and
dispensers recognized the new treatment guidelines, and
were able to identify oral ASP as the first-line treatment
for uncomplicated malaria, a fewer number of them rec-
ognized ASP as a combination therapy. Failure to acknow-
ledge ACT as a combination therapy is troublesome. One
component of the combination therapy, S/P, was previ-
ously used as a second-line treatment. Prior knowledge
about S/P might have caused some confusion for some
health care providers. It is of utmost importance for health
care providers to understand why the use chloroquine has
been discontinued, and it is essential for them to appreci-
ate in what ways ACT is superior to chloroquine. Health
care providers are instrumental for the successful imple-
mentation of the ACT policy in Sudan and their accept-
ance and adherence to this policy is fundamental to
realizing acceptable treatment outcomes. Prior evidence
has correlated poor providers’ adherence to treatment
guidelines with their inadequate knowledge and misper-
ception [19]. Key messages related to what a combination
therapy is, why it is needed, and the particular advantages
it has over chloroquine should always be clearly and ad-
equately incorporated in in-service training progammes.
Further analysis of health care providers’ responses re-
vealed a substantial knowledge deficiency regarding the
dosing regimens of the recommended first and second line
treatments. Similar patterns of providers’ poor knowledge
about doses, predominantly in the private sector, have been
found in low-income countries in Africa [20-22]. Rigorous
knowledge about treatment prescribed to patients is
equally essential to both prescribers and dispensers.
ASP and AL are available pre-packed and are provided
free of charge in primary health facilities. Apparently,
health care providers are less motivated to remembereffectiveness, malaria wall charts & training
Dispensers Total 95% CI Chi-square P. value
N = 47 N = 119
n (%) n (%)
45 110 87.6-97.2 1.216 0.480
95.7 92.4
42 104 83.3-94.5 5.931 0.204
93.3 88.9
9 27 15.4-30.5 0.470 0.654
19.1 22.9
Table 4 Prescribing behaviour of prescribers
Domain Count % 95% CI
Prescriber defined a case of malaria correctly 32 44.4 32.9-55.9
Prescriber relies on laboratory results when
treating malaria
15 22.4 12.8-32.0
Prescriber always prescribe ASP as the first
line for uncomplicated malaria
47 63.2 52.1-74.3
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pre-packed envelope. In some health facilities, prescribing
and dispensing of anti-malarials are both undertaken by
the same health care provider, and that practice in particu-
lar has made matters worse since no prescription is
needed for dispensing the anti-malarial. Dispensing
anti-malarials is thus a habitual process rather than an
organized professional practice in these health facilities.
Haphazard use of ACT resulting from inadequate know-
ledge could have serious implications for patient safety as
well as for emergence of parasite resistance. Training pro-
grammes may need to be more focused, and tailored ac-
cording to the perceived needs of health care providers,
not exclusively delivered as a basic package determined by
health authorities. A training programme that is more re-
sponsive to the felt needs of the target audience is more
likely to produce a positive impact and attain its goals
[23]. However, to ensure safe and effective use of ACT,
training alone is insufficient. Ongoing follow-up and
supervision may be as important as the training itself, and
in settings such as Sudan may actually be more challen-
ging to put into practice than the initial training work-
shops. A clear monitoring system augmented by strict
regulations is also needed to oversee practices, determine
deficiencies and provide timely solutions.
Interestingly, the level of knowledge about the dosage
of the third line anti-malarial (i.e. quinine) was higher
among prescribers compared to their knowledge about
dosages of the first- and second-line treatments. Also, it
was observed that there is a statistically significant dif-
ference in quinine knowledge between prescribers and
dispensers (P = 0.000). The choice of quinine as the third
line treatment has not changed following the introduction
of ACT in Sudan. Most prescribers are fairly familiar with
this particular anti-malarial, and that could explain their
improved knowledge about it. Furthermore, ACT is a rela-
tively new drug due to its recent marketing and imple-
mentation. ACT contains more than one drug, each with
a different dose schedule making it more unlikely for a
health care provider to efficiently recall dosages [20,24].
Regarding the use of injectable quinine, it has been found
that a large number of prescribers and dispensers have
indicated unnecessary reasons for prescribing injections.
Other studies have also shown that injections are oftenunnecessarily used [25]. Greater caution has to be taken
when prescribing injectable anti-malarials to minimize the
hazards associated with this type of preparations. This in-
formation should be explicitly and strictly conveyed to
health care providers.
Overall, the primary outcome of this study was the
proportion of health care providers who were ACT
knowledgeable. Considerably few health care providers
demonstrated adequate knowledge about ACT and could,
therefore, be labelled ‘ACT–knowledgeable’. This is con-
sistent with prior evidence of substantially low level of
knowledge about malaria treatment guidelines in other
countries [26]. The finding sounds alarm bells and may
suggest the need for more effective training and super-
vision to enhance health care providers’ knowledge and
practice.
Regarding health care providers perceptions of the ACT
guidelines, it was found that the majority of both pre-
scribers and dispensers perceive ASP as effective. The ma-
jority described the ACT guidelines wall chart as clear and
informative. Wall charts were present in all study health
facilities at the time data were collected. Wall charts are
helpful aids that can be used by prescribers and dispensers
to readily recall key information. However, while health
care providers have a positive attitude towards wall charts
they do not seem to have effectively assimilated the infor-
mation contained in these charts. Inadequate training is
possibly the main hurdle as most of prescribers and
dispensers indicated that they have not received training
on the ACT guidelines. A previous study in Malawi has
shown similar results [27]. In-service training is one of the
key activities delivered by Gezira state malaria control
programme on an ongoing basis, though adequate infor-
mation about the impact that training has on the per-
formance of health care providers is lacking. A systematic
training needs assessment should be undertaken prior to
conducting in-service training to ensure its effectiveness.
In addition to examining prescribers’knowledge about
ACT, this study explored other facets related to their
prescribing behaviour; specifically, under what conditions
malaria should be suspected, how it should be diagnosed,
and the willingness with which the recommended first-
line is prescribed. Surprisingly, the majority of prescribers
failed to define a case of malaria correctly. Moreover, most
prescribers lacked confidence in laboratory diagnosis and
did not often rely on such results for confirming a diagno-
sis of malaria. Similar patterns have been observed in
Nigeria [28]. More strict regulations are needed to control
prescribing behaviour of health care providers, particularly
at primary level were most malaria patients are seen. Para-
sitological testing of malaria has been found to effectively
reduce the number of anti-malarial prescriptions [29] and
it continues to be the gold standard for confirming the
diagnosis of malaria. However, it was extremely worrying
Mannan et al. Malaria Journal  (2015) 14:131 Page 6 of 7to find that although over 90% of prescribers perceived
ASP as effective only 63.2% actually prescribe it as the first
choice. It is, therefore, worth mentioning that a strong
positive perception about a treatment does not necessarily
translate into adherence to its guidelines. Several studies
have indicated that changing the behaviour of health care
providers is challenging [17,30]. More in-depth analysis is
needed to find out why some prescribers are so reluctant
to prescribe ASP in order to avoid repeating the failures of
the past related to non-compliance to nationally recom-
mended treatment guidelines.
Conclusions
The overall level of knowledge about ACT among pre-
scribers and dispensers is critically low. Investment in fo-
cused training and regular supervision may be needed,
particularly for first-level health care providers on the
frontlines who care for the greatest proportion of malaria
patients. In addition, further research is needed to identify
how best to translate improved providers’ knowledge into
better practice. The goal is substantial reduction of mal-
aria burden on the national health system in Sudan.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AM, EM and KE conceived and designed the study. AM & EM conducted
training of data collectors. YI was responsible for overseeing field work and
contributed to training of data collectors. NA performed data analysis. AM,
EM, NA and JS contributed to interpretation of results. JS provided advice
and critically reviewed study results. All authors read and approved the final
manuscript.
Acknowledgements
We wish to acknowledge the financial support received from the National
Fund for Promoting Medical Services, the National Malaria Control
programme, and Al Neelain University in Sudan. We are thankful to Dr. Sakhr
Omer, the Coordinator of malaria programme in Gezira state for facilitating
field work, and to the field teams who participated in data collection. We are
also indebted to all health care providers who participated in this study.
Author details
1Al Neelain University, Steen Street, P.O. Box 7294, Code: 11123 Khartoum,
Sudan. 2Federal Ministry of Health, Khartoum, Sudan. 3Gezira State Ministry of
Health, Gezira, Sudan. 4Massachusetts General Hospital, 55 Fruit Street,
Boston, MA 02114, USA.
Received: 8 October 2014 Accepted: 16 March 2015
References
1. WHO. World malaria report 2013. Geneva: World Health Organization; 2013.
http://www.who.int/malaria/publications/world_malaria_report_2013/en/
index.html, accessed 10 April 2014.
2. Abdalla SI, Malik EM, Ali KM. The burden of malaria in Sudan: incidence,
mortality and disability-adjusted life-years. Malar J. 2007;6:97.
3. WHO. Guidelines for the treatment of malaria. Geneva: World Health
Organization; 2006.
4. Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital
tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864–74.
5. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based
combination therapy for treating uncomplicated malaria. CochraneDatabase of Systematic Reviews 2009, Issue 3. Art. No.: CD007483.
doi:10.1002/14651858.CD007483.pub2.
6. Adeyi O, Atun R. Universal access to malaria medicines: innovation in
financing and delivery. Lancet. 2010;376:1869–71.
7. Malisa AL, Kiriba D. Artemisinin combination therapies price disparity
between government and private health sectors and its implication on
antimalarial drug consumption pattern in Morogoro Urban District. Tanzania
BMC Res Notes. 2012;5:165.
8. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope
for malaria treatment but inaccessible to the needy! Acta Trop. 2005;95:305–15.
9. Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB,
et al. From chloroquine to artemisinin-based combination therapy: the
Sudanese experience. Malar J. 2006;5:65.
10. Abdelgader TM, Ibrahim AM, Elmardi KA, Githinji S, Zurovac D, Snow RW,
et al. Progress towards implementation of ACT malaria case-management in
public health facilities in the Republic of Sudan: a cluster-sample survey.
BMC Public Health. 2012;12:11.
11. Kamal-Yanni M, Potet J, Saunders P. Scaling-up malaria treatment: a review
of the performance of different providers. Malar J. 2012;11:414.
12. Okeke TA, Uzochukwu BSC, Okafor HU. An in-depth study of patent
medicine sellers’ perspectives on malaria in a rural Nigerian community.
Malar J. 2006;5:97.
13. Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D. A comparison
of prescribing practices between public and private sector physicians in
Uganda. East Afr Med J. 2004, (Suppl):S12-6.
14. Leonard K, Masatu MC, Vialou A. Getting doctors to do their best. J Hum
Resour. 2007;42:682–700.
15. Das J, Hammer J. Money for nothing: the dire straits of medical practice in
Delhi, India. J Dev Econ. 2007;83:1–36.
16. Gross K, Pfeiffer C, Obrist B. “Workhood”-a useful concept for the analysis of
health workers’ resources? An evaluation from Tanzania. BMC Health Serv
Res. 2012;12:55.
17. Rowe AK, De Savigny D, Lanata CF, Victora CG. How can we achieve and
maintain high-quality performance of health workers in low-resource
settings? Lancet. 2005;366:1026–35.
18. Elmahdi ZA, Nugud AA, Elhassan IM. Estimation of malaria transmission
intensity in Sennar state, central Sudan. East Mediterr Health J. 2012;8:951–6.
19. Walter ND, Lyimo T, Skarbinski J, Metta E, Kahigwa E, Flannery B, et al. Why
first-level health workers fail to follow guidelines for managing severe
disease in children in the Coast Region, the United Republic of Tanzania.
Bull World Health Organ. 2009;87:99–107.
20. Wafula FN, Goodman CA. Are interventions for improving the quality of
services provided by specialized drug shops effective in sub-Saharan Africa?
A systematic review of the literature. Int J Qual Health Care. 2010;22:316–23.
21. Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, et al.
Obstacles to prompt and effective malaria treatment lead to low
community-coverage in two rural districts of Tanzania. BMC Public Health.
2008;16:317.
22. Minzi OM, Haule AF. Poor knowledge on new malaria treatment guidelines
among drug dispensers in private pharmacies in Tanzania: the need for
involving the private sector in policy preparations and implementation. East
African J Public Health. 2008;5:117–21.
23. Mbacham WF, Mangham-Jefferies L, Cundill B, Achonduh OA, Chandler CI,
Ambebila JN, et al. Basic or enhanced clinician training to improve adher-
ence to malaria treatment guidelines: a cluster-randomised trial in two areas
of Cameroon. Lancet Glob Health. 2014;2:e346–58.
24. O’Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, et al. Got
ACTs? Availability, price, market share and provider knowledge of
anti-malarial medicines in public and private sector outlets in six
malaria-endemic countries. Malar J. 2011;10:326.
25. Chareonkul C, Khun VL, Boonshuyar C. Rational drug use in Cambodia.
Study of three pilot health centres in Kampong Thom Province. Southeast
Asian J Trop Med Public Health. 2002;33:418–24.
26. Smith LA, Jones C, Meek S, Webster J. Provider practice and user behavior
interventions to improve prompt and effective treatment of malaria: do we
know what works? Am J Trop Med Hyg. 2009;80:326–35.
27. Kalilani-Phiri LV, Lungu D, Coghlan R. Knowledge and malaria treatment
practices using artemisinin combination therapy (ACT) in Malawi: survey of
health professionals. Malar J. 2011;10:279.
28. Onwujekwe O, Uzochukwu B, Dike N, Uguru N, Nwobi E, Shu E. Malaria
treatment perceptions, practices and influences on provider behaviour:
Mannan et al. Malaria Journal  (2015) 14:131 Page 7 of 7comparing hospitals and non-hospitals in south-east Nigeria. Malar J.
2009;8:246.
29. Chitaka R, Khare AK, Brickling C. Prescribing policy for antimalarials. Afr
Health. 1998;20:2–5.
30. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a
systematic review of 102 trials of interventions to improve professional
practice. CMAJ. 1995;153:1423–31.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
